` 600329 (Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd) vs Shanghai Composite Comparison - Alpha Spread

600329
vs
Shanghai Composite

Over the past 12 months, has underperformed Shanghai Composite, delivering a return of -11% compared to the Shanghai Composite's 7% growth.

Stocks Performance
600329 vs Shanghai Composite

Loading
600329
Shanghai Composite
Add Stock

Performance Gap
600329 vs Shanghai Composite

Loading
600329
Shanghai Composite
Difference

Performance By Year
600329 vs Shanghai Composite

Loading
600329
Shanghai Composite
Add Stock

Competitors Performance
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd vs Peers

Shanghai Composite
600329
LLY
JNJ
NOVO B
ROG
Add Stock

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Glance View

Market Cap
23.2B CNY
Industry
Pharmaceuticals

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, rooted in the rich tapestry of traditional Chinese medicine, has carved out a substantial presence in the pharmaceutical industry. Established in a region known for its deep cultural heritage in holistic healing, the company seamlessly weaves ancient practices with modern scientific advancements. At the core of its operations, Da Ren Tang specializes in the research, development, production, and distribution of traditional Chinese medicine and pharmaceuticals. Beyond just leveraging ancient recipes, the company invests significantly in cutting-edge research to validate and enhance the efficacy of its formulations, gaining trust not only domestically but also in international markets. This blending of tradition and innovation enables Da Ren Tang to capture a diverse customer base, ranging from individuals seeking natural remedies to medical institutions incorporating holistic approaches into patient care. The economic engine of Da Ren Tang powers through a multi-faceted monetization strategy. It manufactures a broad portfolio of pharmaceutical products, including patented Chinese medicines and active pharmaceutical ingredients (APIs), which are distributed through a well-established network of pharmacies and healthcare providers. Additionally, the company has embraced the digital era by exploring e-commerce platforms, thereby expanding its reach and accessibility to tech-savvy consumers globally. By maintaining stringent quality controls and adopting sustainable practices in its production processes, Da Ren Tang not only enhances its reputation but also adheres to evolving regulatory standards worldwide. Such strategic positioning allows the company to capitalize on the growing global interest in traditional medicines, contributing significantly to its revenue streams and reinforcing its status as a prominent player in the pharmaceutical landscape.

Intrinsic Value
37.28 CNY
Undervaluation 19%
Intrinsic Value
Price
Back to Top